You are viewing a single comment's thread.

view the rest of the comments →

VoatisCIA ago

Bronfman-Rothschild Buy up stock in biotech giant Biogen

Link http://bangaloreweekly.com/2018-05-20-bronfman-e-l-rothschild-l-p-reaches-725000-position-of-biogen-inc-biib/

BRONFMAN E.L. ROTHSCHILD L.P. ATTAINS $725,000 POSITION OF BIOGEN INC. (BIIB)

neptunium1 ago

Several other hedge funds have also bought and sold shares of BIIB. Vanguard Group Inc. boosted its position in shares of Biogen by 1.4% in the second quarter. Vanguard Group Inc. now owns 13,544,616 shares of the biotechnology company’s stock valued at $3,275,359,000 after buying an additional 182,714 shares in the last quarter. BlackRock Institutional Trust Company N.A. boosted its position in shares of Biogen by 0.9% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 5,816,485 shares of the biotechnology company’s stock valued at $1,406,542,000 after buying an additional 50,433 shares in the last quarter. BlackRock Fund Advisors boosted its position in shares of Biogen by 1.5% in the second quarter. BlackRock Fund Advisors now owns 4,843,447 shares of the biotechnology company’s stock valued at $1,171,242,000 after buying an additional 71,709 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of Biogen by 0.7% in the second quarter.